US 11897933
Anti-KRAS-G12D T cell receptors
granted A61KA61K38/00A61P
Quick answer
US patent 11897933 (Anti-KRAS-G12D T cell receptors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K38/00, A61P, A61P35/00